RLYB
Price:
$15.97
Market Cap:
$92.63M
Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Its most advanced therapeutic candidate, RLYB212, is a monoclonal anti-HPA-1a antibody currently undergoing Phase II clinical trials. This candidate, along with RLYB211, is aimed at preventing fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company's pipeline also includes RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for addressing ophthalmic conditions driven by complement system activity. Furthermore, RLYB116, an inhibitor designed to targe...[Read more]
Industry
Biotechnology
IPO Date
2021-07-29
Stock Exchange
NASDAQ
Ticker
RLYB
According to Rallybio Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -11.74. This represents a change of 1.57% compared to the average of -0.70 of the last 4 quarters.
The mean historical PE Ratio of Rallybio Corporation over the last ten years is -7.52. The current -11.74 PE Ratio has changed 15.51% with respect to the historical average. Over the past ten years (40 quarters), RLYB's PE Ratio was at its highest in in the September 2025 quarter at 0.35. The PE Ratio was at its lowest in in the March 2020 quarter at -20.74.
Average
-7.52
Median
-3.45
Minimum
-25.64
Maximum
-0.72
Discovering the peaks and valleys of Rallybio Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 378.36%
Maximum Annual PE Ratio = -0.72
Minimum Annual Increase = -58.68%
Minimum Annual PE Ratio = -25.64
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.45 | 378.36% |
| 2024 | -0.72 | -44.43% |
| 2023 | -1.30 | -58.68% |
| 2022 | -3.14 | -51.89% |
| 2021 | -6.53 | -44.85% |
| 2020 | -11.85 | -53.78% |
The current PE Ratio of Rallybio Corporation (RLYB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.82
5-year avg
-3.03
10-year avg
-7.52
Rallybio Corporation’s PE Ratio is less than Intensity Therapeutics, Inc. (-0.56), less than Sonnet BioTherapeutics Holdings, Inc. (-0.32), less than Iterum Therapeutics plc (-0.06), less than TAO Synergies Inc. (-0.27), less than iBio, Inc. (-2.94), less than Klotho Neurosciences, Inc. (-1.08), less than Cadrenal Therapeutics, Inc. Common Stock (-0.62), less than Exicure, Inc. (-1.50), less than Boundless Bio, Inc. (-0.57), less than Q32 Bio Inc. (4.44),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.56 | $7.39M | |
| -0.32 | $8.43M | |
| -0.06 | $1.60M | |
| -0.27 | $12.06M | |
| -2.94 | $26.68M | |
| -1.08 | $20.08M | |
| -0.62 | $10.04M | |
| -1.50 | $14.72M | |
| -0.57 | $32.12M | |
| 4.44 | $152.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rallybio Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rallybio Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Rallybio Corporation's PE Ratio?
How is the PE Ratio calculated for Rallybio Corporation (RLYB)?
What is the highest PE Ratio for Rallybio Corporation (RLYB)?
What is the 3-year average PE Ratio for Rallybio Corporation (RLYB)?
What is the 5-year average PE Ratio for Rallybio Corporation (RLYB)?
How does the current PE Ratio for Rallybio Corporation (RLYB) compare to its historical average?